Cargando…
NAFLD in the Elderly
Non-alcoholic fatty liver disease (NAFLD) is an increasingly prevalent disease globally. Current estimates are that 24% of the adult population, thus, one billion individuals worldwide, are affected. Interestingly, the prevalence of fatty liver seems to peak between 40─50 years of age in males and 6...
Autores principales: | Alqahtani, Saleh A, Schattenberg, Jörn M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448161/ https://www.ncbi.nlm.nih.gov/pubmed/34548787 http://dx.doi.org/10.2147/CIA.S295524 |
Ejemplares similares
-
Liver injury in COVID-19: The current evidence
por: Alqahtani, Saleh A, et al.
Publicado: (2020) -
Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019) -
Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
por: Schattenberg, Jörn M., et al.
Publicado: (2022) -
Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020) -
A multistakeholder approach to innovations in NAFLD care
por: Schattenberg, Jörn M., et al.
Publicado: (2023)